These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 17973541)

  • 1. Adverse drug reactions in patients with phaeochromocytoma: incidence, prevention and management.
    Eisenhofer G; Rivers G; Rosas AL; Quezado Z; Manger WM; Pacak K
    Drug Saf; 2007; 30(11):1031-62. PubMed ID: 17973541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Undiagnosed phaeochromocytoma in the perioperative period. Case reports.
    Sellevold OF; Raeder J; Stenseth R
    Acta Anaesthesiol Scand; 1985 Jul; 29(5):474-9. PubMed ID: 4036531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subclinical phaeochromocytoma.
    Mannelli M; Lenders JW; Pacak K; Parenti G; Eisenhofer G
    Best Pract Res Clin Endocrinol Metab; 2012 Aug; 26(4):507-15. PubMed ID: 22863392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phaeochromocytoma unmasked by drug therapy.
    Prescrire Int; 2003 Oct; 12(67):181-2. PubMed ID: 14619898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different expression of catecholamine transporters in phaeochromocytomas from patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2.
    Huynh TT; Pacak K; Brouwers FM; Abu-Asab MS; Worrell RA; Walther MM; Elkahloun AG; Goldstein DS; Cleary S; Eisenhofer G
    Eur J Endocrinol; 2005 Oct; 153(4):551-63. PubMed ID: 16189177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromogranin a expression in phaeochromocytomas associated with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2.
    Cleary S; Phillips JK; Huynh TT; Pacak K; Fliedner S; Elkahloun AG; Munson P; Worrell RA; Eisenhofer G
    Horm Metab Res; 2007 Dec; 39(12):876-83. PubMed ID: 18046660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A rare cause of cardiogenic shock treated by extracorporeal life support: catecholamine secreting paraganglioma].
    Xeridat F; Vidal V; Puech JB; Gariboldi V; Kerbaul F
    Ann Fr Anesth Reanim; 2011 Apr; 30(4):363-5. PubMed ID: 21411267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pheochromocytoma--rare and often undiagnosed condition].
    Manhem P; Wahrenberg H
    Lakartidningen; 2002 Mar; 99(14):1585-9. PubMed ID: 12025214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute heart failure and transient low voltage in electrocardiogram after massive catecholamine release from a phaeochromocytoma.
    Kokkonen JO; Lammintausta O; Luomanmäki K
    Eur Heart J; 1997 Aug; 18(8):1357. PubMed ID: 9458431
    [No Abstract]   [Full Text] [Related]  

  • 10. A rare cause of cardiogenic shock: catecholamine cardiomyopathy of pheochromocytoma.
    Imperadore F; Azzolini M; Piscioli F; Pusiol T; Capitanio A; Vergara G
    Ital Heart J; 2002 Jun; 3(6):375-8. PubMed ID: 12116803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative pharmacological management of phaeochromocytoma.
    van der Horst-Schrivers AN; Kerstens MN; Wolffenbuttel BH
    Neth J Med; 2006 Sep; 64(8):290-5. PubMed ID: 16990692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient shock and myocardial impairment caused by phaeochromocytoma crisis.
    Shaw TR; Rafferty P; Tait GW
    Br Heart J; 1987 Feb; 57(2):194-8. PubMed ID: 3814455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous biopsy of adrenal and extra-adrenal retroperitoneal lesions: beware of catecholamine secreting tumours!
    Sood SK; Balasubramanian SP; Harrison BJ
    Surgeon; 2007 Oct; 5(5):279-81. PubMed ID: 17958227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naloxone provokes catecholamine release in phaeochromocytomas and paragangliomas.
    Bouloux PM; Grossman A; Besser GM
    Clin Endocrinol (Oxf); 1986 Mar; 24(3):319-25. PubMed ID: 3708878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phaeochromocytomas as a cause of hypotension.
    Baxter MA; Hunter P; Thompson GR; London DR
    Clin Endocrinol (Oxf); 1992 Sep; 37(3):304-6. PubMed ID: 1424214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular manifestations of phaeochromocytoma.
    Prejbisz A; Lenders JW; Eisenhofer G; Januszewicz A
    J Hypertens; 2011 Nov; 29(11):2049-60. PubMed ID: 21826022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catecholamine cardiotoxicity in pheochromocytoma.
    Ganguly PK; Beamish RE; Dhalla NS
    Am Heart J; 1989 Jun; 117(6):1399-400. PubMed ID: 2729074
    [No Abstract]   [Full Text] [Related]  

  • 18. Phaeochromocytoma still surprises.
    Lancet; 1990 May; 335(8699):1189-90. PubMed ID: 1971040
    [No Abstract]   [Full Text] [Related]  

  • 19. [Endocrine arterial hypertension. Pheochromocytoma].
    Telles EC; Machado FS; Bicho MP; Rego F; Almeida G; Amram S
    Acta Med Port; 1989; 2(1):41-5. PubMed ID: 2672701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergency resection of an extra-adrenal phaeochromocytoma: wrong or right? A case report and a review of literature.
    Bos JC; Toorians AW; van Mourik JC; van Schijndel RJ
    Neth J Med; 2003 Aug; 61(8):258-65. PubMed ID: 14628962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.